Oramed Pharmaceuticals Inc(ORMP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORMP Oramed Pharmaceuticals Inc

未开盘 03-24 16:00:00 EDT

3.42

-0.13

-3.66%

盘后3.38

-0.04-1.17%

16:10 EDT

最高3.55	最低3.37	成交量17.47万
今开3.54	昨收3.55	日振幅5.07%
总市值1.36亿	流通市值1.11亿	总股本3,980万
成交额60.51万	换手率0.54%	流通股本3,256万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORMP","market":"US","secType":"STK","nameCN":"Oramed Pharmaceuticals Inc","latestPrice":3.42,"timestamp":1774382400000,"preClose":3.55,"halted":0,"volume":174719,"hourTrading":{"tag":"盘后","latestPrice":3.38,"preClose":3.42,"latestTime":"16:10 EDT","volume":1308,"amount":4429.4,"timestamp":1774383004267,"change":-0.04,"changeRate":-0.011696,"amplitude":0.011696},"delay":0,"changeRate":-0.03661971830985913,"floatShares":32556743,"shares":39802455,"eps":1.026987,"marketStatus":"未开盘","change":-0.13,"latestTime":"03-24 16:00:00 EDT","open":3.54,"high":3.55,"low":3.37,"amount":605067.149969,"amplitude":0.050704,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.026987,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.55,"preHourTrading":{"tag":"盘前","latestPrice":3.4394,"preClose":3.55,"latestTime":"09:02 EDT","volume":715,"amount":2488.4543255,"timestamp":1774357349700,"change":-0.1106,"changeRate":-0.031155,"amplitude":0.073239},"postHourTrading":{"tag":"盘后","latestPrice":3.38,"preClose":3.42,"latestTime":"16:10 EDT","volume":1308,"amount":4429.4,"timestamp":1774383004267,"change":-0.04,"changeRate":-0.011696,"amplitude":0.011696},"volumeRatio":1.850884,"impliedVol":1.5854,"impliedVolPercentile":0.9721},"requestUrl":"/m/hq/s/ORMP/tweets","defaultTab":"tweets","newsList":[{"id":"1167086556","title":"Lifeward获股东批准与Oramed达成战略合作——组建多元化生物医学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1167086556","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167086556?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:01","pubTimestamp":1773403273,"startTime":"0","endTime":"0","summary":"Lifeward公司已获得股东批准，即将完成与Oramed Pharmaceuticals Inc（纳斯达克：ORMP）的战略合作。这一关键进展标志着两家公司正式整合资源，共同组建一家业务多元化的生物医学企业。此次合作将结合双方在医疗技术领域的专长，有望推动创新疗法的研发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2612262986","title":"Oramed Pharmaceuticals Inc.盘中异动 早盘股价大跌5.00%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612262986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612262986?lang=zh_cn&edition=full","pubTime":"2026-02-19 23:55","pubTimestamp":1771516557,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日23时55分，Oramed Pharmaceuticals Inc.股票出现异动，股价急速下挫5.00%。截至发稿，该股报3.14美元/股，成交量6.269万股，换手率0.16%，振幅4.55%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219235557a4b3c3ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219235557a4b3c3ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"1151821521","title":"Lifeward与Oramed达成变革性战略投资与合作协议，共同打造多元化生物医学创新企业","url":"https://stock-news.laohu8.com/highlight/detail?id=1151821521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151821521?lang=zh_cn&edition=full","pubTime":"2026-01-13 21:12","pubTimestamp":1768309965,"startTime":"0","endTime":"0","summary":"Lifeward与Oramed Pharmaceuticals Inc.已签署一项具有变革意义的战略投资与合作协议，双方将携手组建一家多元化的生物医学创新公司。此次合作旨在整合双方优势资源，共同推动前沿医疗技术的研发与应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"1192150078","title":"Oramed Pharmaceuticals Inc.获Scilex Holdings支付1800万美元，累计收益达1.18亿美元；董事会批准股息派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1192150078","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192150078?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:56","pubTimestamp":1767794175,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals Inc.宣布，已从Scilex Holdings处收到一笔1800万美元的付款。这一进账使得公司当前的总收益攀升至1.18亿美元。与此同时，公司董事会已正式批准进行股息派发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"1181278342","title":"Oramed Pharmaceuticals Inc. 维持认股权证头寸并持有Scilex产品九年期特许权权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1181278342","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181278342?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:56","pubTimestamp":1767794174,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals Inc. 在保持其认股权证头寸的同时，还持有一项针对Scilex产品的长期特许权权益，该权益的有效期为九年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"1167928192","title":"Oramed Pharmaceuticals 于10月20日与Htit Biotech签订股票回购协议 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1167928192","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167928192?lang=zh_cn&edition=full","pubTime":"2025-10-24 18:04","pubTimestamp":1761300249,"startTime":"0","endTime":"0","summary":"Oramed Pharmaceuticals 于10月20日与Htit Biotech签订股票回购协议 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2575771708","title":"Oramed Pharmaceuticals Inc.盘中异动 下午盘快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575771708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575771708?lang=zh_cn&edition=full","pubTime":"2025-10-16 01:03","pubTimestamp":1760547834,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日01时03分，Oramed Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.08%。截至发稿，该股报2.24美元/股，成交量18.6415万股，换手率0.45%，振幅4.81%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。开发了一种口服剂型，旨在承受胃的恶劣环境并有效递送活性生物胰岛素或其他蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016010354a461bdb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016010354a461bdb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2517600804","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大涨5.00%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517600804?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:30","pubTimestamp":1741113042,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时30分，Oramed Pharmaceuticals Inc.股票出现波动，股价急速上涨5.00%。截至发稿，该股报2.10美元/股，成交量21.3094万股，换手率0.53%，振幅7.00%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502304296397e46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502304296397e46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"2510805673","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大涨5.99%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510805673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510805673?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284277,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Oramed Pharmaceuticals Inc.股票出现异动，股价急速拉升5.99%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为1854.98%、501.30%、169.12%，振幅较大的相关个股有In8Bio, Inc.、Dominari Holdings Inc.、Abpro Holdings, Inc，振幅分别为11.26%、8.28%、6.12%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223118961f4778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223118961f4778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2508492421","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508492421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508492421?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593365,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Oramed Pharmaceuticals Inc.股票出现波动，股价大幅下跌5.36%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为355.09%、309.60%、145.69%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、27.90%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322360598796fc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322360598796fc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2492918441","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492918441?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:34","pubTimestamp":1734532465,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时34分，Oramed Pharmaceuticals Inc.股票出现波动，股价快速上涨5.53%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1048.99%、309.44%、244.01%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Polyrizon Ltd.、Cognition Therapeutics, Inc.，振幅分别为66.83%、63.81%、48.36%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223426ab82076a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223426ab82076a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"2489250325","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489250325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489250325?lang=zh_cn&edition=full","pubTime":"2024-12-07 02:58","pubTimestamp":1733511502,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日02时58分，Oramed Pharmaceuticals Inc.股票出现波动，股价快速下跌5.16%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Surrozen Inc C/Wts 01/08/2031 、Adc Therapeutics Sa涨幅较大，Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.、Molecular Templates, Inc.较为活跃，换手率分别为154.41%、107.89%、89.09%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为191.67%、99.12%、80.81%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207025822a1d9ed48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207025822a1d9ed48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"2488600853","title":"Oramed Pharmaceuticals Inc.盘中异动 下午盘急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488600853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488600853?lang=zh_cn&edition=full","pubTime":"2024-12-03 03:23","pubTimestamp":1733167428,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日03时23分，Oramed Pharmaceuticals Inc.股票出现波动，股价大幅上涨5.06%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2814.47%、2610.17%、659.79%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120303234998e4f4e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120303234998e4f4e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2484927926","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484927926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484927926?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:34","pubTimestamp":1732034049,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时34分，Oramed Pharmaceuticals Inc.股票出现异动，股价快速上涨5.07%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Syros Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为811.02%、165.07%、122.47%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Syros Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为81.67%、80.89%、62.18%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120003409971a77bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120003409971a77bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORMP","BK4007"],"gpt_icon":0},{"id":"2479978445","title":"Oramed Pharmaceuticals Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479978445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479978445?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:43","pubTimestamp":1730299435,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时43分，Oramed Pharmaceuticals Inc.股票出现异动，股价快速上涨5.24%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4063.74%、1611.56%、79.34%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.，振幅分别为100.99%、72.82%、47.63%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030224355971a3432&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030224355971a3432&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2470087968","title":"Oramed Pharmaceuticals Inc.盘中异动 早盘大幅拉升5.83%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470087968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470087968?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:44","pubTimestamp":1727448253,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时44分，Oramed Pharmaceuticals Inc.股票出现异动，股价快速上涨5.83%。截至发稿，该股报2.54美元/股，成交量2.6416万股，换手率0.06%，振幅5.00%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272244139719d24c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272244139719d24c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0},{"id":"2469608347","title":"Oramed Pharmaceuticals Inc.盘中异动 下午盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469608347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469608347?lang=zh_cn&edition=full","pubTime":"2024-09-21 02:57","pubTimestamp":1726858640,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日02时57分，Oramed Pharmaceuticals Inc.股票出现波动，股价快速下跌5.26%。截至发稿，该股报2.34美元/股，成交量8.8358万股，换手率0.22%，振幅5.23%。Oramed Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为2.27%。Oramed Pharmaceuticals Inc.公司简介：Oramed Pharmaceuticals Inc是一家制药公司，从事药物解决方案的研发，其技术平台允许口服治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092102572098e384d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092102572098e384d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORMP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oramed.com","stockEarnings":[{"period":"1week","weight":-0.0526},{"period":"1month","weight":0.0621},{"period":"3month","weight":0.0857},{"period":"6month","weight":0.425},{"period":"1year","weight":0.4615},{"period":"ytd","weight":0.2}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oramed Pharmaceuticals Inc.是特拉华州的一家公司，于2002年4月12日注册成立。该公司是一家从事研发创新制药解决方案的制药公司，其技术平台允许口服递送治疗性蛋白质。该公司开发了一种口服剂型，旨在抵御胃的恶劣环境，并有效递送活性生物胰岛素或蛋白质。配方中的辅料不是为了对蛋白质进行化学或生物修饰，剂型的设计是为了可以安全摄入。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.018109},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.018104},{"month":3,"riseRate":0.5,"avgChangeRate":-0.012396},{"month":4,"riseRate":0.769231,"avgChangeRate":0.017276},{"month":5,"riseRate":0.538462,"avgChangeRate":0.041552},{"month":6,"riseRate":0.384615,"avgChangeRate":0.018782},{"month":7,"riseRate":0.461538,"avgChangeRate":0.04461},{"month":8,"riseRate":0.384615,"avgChangeRate":0.00834},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.048853},{"month":10,"riseRate":0.307692,"avgChangeRate":-0.028699},{"month":11,"riseRate":0.538462,"avgChangeRate":0.137309},{"month":12,"riseRate":0.384615,"avgChangeRate":0.051334}],"exchange":"NASDAQ","name":"Oramed Pharmaceuticals Inc","nameEN":"Oramed Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oramed Pharmaceuticals Inc(ORMP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oramed Pharmaceuticals Inc(ORMP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oramed Pharmaceuticals Inc,ORMP,Oramed Pharmaceuticals Inc股票,Oramed Pharmaceuticals Inc股票老虎,Oramed Pharmaceuticals Inc股票老虎国际,Oramed Pharmaceuticals Inc行情,Oramed Pharmaceuticals Inc股票行情,Oramed Pharmaceuticals Inc股价,Oramed Pharmaceuticals Inc股市,Oramed Pharmaceuticals Inc股票价格,Oramed Pharmaceuticals Inc股票交易,Oramed Pharmaceuticals Inc股票购买,Oramed Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oramed Pharmaceuticals Inc(ORMP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oramed Pharmaceuticals Inc(ORMP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}